Concepedia

Praechompoo Pongtornpipat

PP

6

Publications

242

Citations

6

H-Index

2012

Active since

Affiliations

University of Arizona(Current)

University of Miami

Sylvester Comprehensive Cancer Center

Praechompoo Pongtornpipat is an author at University of Arizona specializing in pharmacology, cell death, and medicine.

Top concepts

Publications per year

2012–2018

6

Publications

6

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1

Lucy Li, Praechompoo Pongtornpipat, Timothy Tiutan et al. · Leukemia · 2015 · 95 citations · Full text

, , +11

Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors

Amit Dipak Amin, Soumya Sundara Rajan, Winnie S. Liang et al. · Cancer Research · 2015 · 45 citations · Full text

Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with <i>In Vivo</i> Antitumor Activity

Tara L. Peters, Joseph Tillotson, Alison Yeomans et al. · Clinical Cancer Research · 2018 · 43 citations · Full text

Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447

Tara L. Peters, Lingxiao Li, Ana A. Tula-Sanchez et al. · Oncotarget · 2016 · 23 citations · Full text

TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors

Amit Dipak Amin, Lingxiao Li, Soumya Sundara Rajan et al. · Oncotarget · 2016 · 22 citations · Full text

Rows per page

1–5 of 6